ArticleBiology open2026
Conserved roles of GATA4 and its target gene TBX2 in regulation of human cardiogenesis.
Article in Biology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The transcription factor GATA4 is a key mediator of cardiogenesis, regulating this process through the expression of downstream target genes, only a subset of which have been identified. Using a gain-of-function model based on pluripotent ectoderm explants from Xenopus embryos expressing GATA4, we identified a set of GATA4 targets that are also regulated by cardiogenic Nodal signalling. GATA4 was shown to be required for the expression of the target genes tbx2 and prdm1, both of which were subsequently found to have roles of their own in vivo, as downregulation of tbx2, a positive target, and overexpression of prdm1, a negative target, interferes with cardiac development in Xenopus embryos. The conservation of the GATA4-TBX2-PRDM1 regulatory relationship was demonstrated in human induced pluripotent stem cell-derived cardiomyocytes. Loss of GATA4 function resulted in downregulation of TBX2, upregulation of PRDM1 and failure of cardiogenesis. GATA4-deficient cells failed to form normal cardiomyocytes, with most cells adopting alternative fates and only a small minority displaying an aberrant cardiomyocyte phenotype. Genome-wide transcriptomic analysis documented a marked reduction in cardiomyocyte and endothelial cell transcriptomes, accompanied by upregulation of transcriptional profiles associated with smooth muscle cells and fibroblasts. Disruption of TBX2 led to the formation of cardiomyocytes with hypertrophic-like features consistent with maladaptive remodelling. In addition, although PRDM1 was not essential for cardiomyocyte formation, it appeared to play a role in fine-tuning the timing and levels of gene expression. Together, these findings establish a conserved regulatory relationship between GATA4 and its target genes TBX2 and PRDM1 and suggest important roles for these factors in modulating cardiomyocyte development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.